MARATTO

article · Tissue and Cell

The angiotensin II receptor blocker candesartan mitigates cisplatin-induced myocardial injury via suppression of TLR-4/NF-κB/IRF-3/AP-1 signaling and restoration of antioxidant defenses

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Chemotherapy-induced cardiotoxicity and mitigation
  • Chemotherapy-induced organ toxicity mitigation
  • Effects of Radiation Exposure

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.tice.2026.103452

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.